Evidence from 40 Studies that 2 Common Single-Nucleotide Polymorphisms (SNPs) of RNASEL Gene Affect Prostate Cancer Susceptibility: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Compliant Meta-Analysis
- PMID: 31686670
- PMCID: PMC6857427
- DOI: 10.12659/MSM.917715
Evidence from 40 Studies that 2 Common Single-Nucleotide Polymorphisms (SNPs) of RNASEL Gene Affect Prostate Cancer Susceptibility: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Compliant Meta-Analysis
Abstract
BACKGROUND Numerous studies have evaluated the relationship between RNASEL gene polymorphisms (rs486907 G>A and rs627928 T>G) and the risk of cancer. However, many of the results have been controversial. To explore the role of RNASEL gene polymorphisms in prostate cancer, we carried out the present meta-analysis. MATERIAL AND METHODS The qualified articles were collected from PubMed, Web of Science, Scopus, CNKI, and WanFang databases to August 2018. A total 23 articles with 40 studies were incorporated into our analysis. RESULTS Our data show that rs486907 was not associated with the risk of prostate cancer in any populations. Nevertheless, rs627928 was reported to promote the development of prostate cancer (T vs. G: OR=1.08, 95% CI=1.01-1.15; TT+TG vs. GG: OR=1.14, 95% CI=1.03-1.25) in allele and recessive models in overall populations. Stratified analyses showed that similar results were obtained in white populations. CONCLUSIONS We report the effect of rs627928 on the development of prostate cancer and confirm that rs486907 is not involved in the risk of prostate cancer in the current meta-analysis. However, research in larger populations is needed to validate our conclusions.
Conflict of interest statement
None.
Figures




Similar articles
-
RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.Mol Biol Rep. 2012 Mar;39(3):2347-53. doi: 10.1007/s11033-011-0985-x. Epub 2011 Jun 9. Mol Biol Rep. 2012. PMID: 21656378
-
Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.Gene. 2019 May 25;698:186-197. doi: 10.1016/j.gene.2019.02.070. Epub 2019 Mar 5. Gene. 2019. PMID: 30849545
-
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.Prostate. 2008 Dec 1;68(16):1790-7. doi: 10.1002/pros.20841. Prostate. 2008. PMID: 18767027 Free PMC article.
-
Prognostic role of genetic biomarkers in clinical progression of prostate cancer.Exp Mol Med. 2015 Aug 7;47(8):e176. doi: 10.1038/emm.2015.43. Exp Mol Med. 2015. PMID: 26251261 Free PMC article.
-
The RNASEL -1385G/A polymorphism is associated with risk of prostate cancer in Africans.Onco Targets Ther. 2017 Dec 22;11:97-102. doi: 10.2147/OTT.S151398. eCollection 2018. Onco Targets Ther. 2017. PMID: 29317837 Free PMC article. Review.
Cited by
-
Template-Independent Poly(A)-Tail Decay and RNASEL as Potential Cellular Biomarkers for Prostate Cancer Development.Cancers (Basel). 2022 Apr 29;14(9):2239. doi: 10.3390/cancers14092239. Cancers (Basel). 2022. PMID: 35565367 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous